ARVN
Price
$7.76
Change
-$0.32 (-3.96%)
Updated
Aug 28 closing price
Capitalization
569.72M
74 days until earnings call
VCYT
Price
$30.61
Change
+$0.66 (+2.20%)
Updated
Aug 29, 02:50 PM (EDT)
Capitalization
2.36B
74 days until earnings call
Interact to see
Advertisement

ARVN vs VCYT

Header iconARVN vs VCYT Comparison
Open Charts ARVN vs VCYTBanner chart's image
Arvinas
Price$7.76
Change-$0.32 (-3.96%)
Volume$1.29M
Capitalization569.72M
Veracyte
Price$30.61
Change+$0.66 (+2.20%)
Volume$205
Capitalization2.36B
ARVN vs VCYT Comparison Chart in %
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. VCYT commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Buy and VCYT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ARVN: $7.76 vs. VCYT: $29.95)
Brand notoriety: ARVN and VCYT are both not notable
ARVN represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ARVN: 61% vs. VCYT: 64%
Market capitalization -- ARVN: $569.72M vs. VCYT: $2.36B
ARVN [@Biotechnology] is valued at $569.72M. VCYT’s [@Medical Specialties] market capitalization is $2.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B. The average market capitalization across the [@Medical Specialties] industry is $10.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 1 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • ARVN’s FA Score: 1 green, 4 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, ARVN is a better buy in the long-term than VCYT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 5 bullish TA indicator(s).

  • ARVN’s TA Score: 4 bullish, 6 bearish.
  • VCYT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than ARVN.

Price Growth

ARVN (@Biotechnology) experienced а +6.30% price change this week, while VCYT (@Medical Specialties) price change was +1.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.09%, and the average quarterly price growth was +29.14%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.22%. For the same industry, the average monthly price growth was +8.00%, and the average quarterly price growth was +7.82%.

Reported Earning Dates

ARVN is expected to report earnings on Nov 11, 2025.

VCYT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (-0.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($2.36B) has a higher market cap than ARVN($570M). VCYT YTD gains are higher at: -24.369 vs. ARVN (-59.520). VCYT has higher annual earnings (EBITDA): 52M vs. ARVN (-112.6M). ARVN has more cash in the bank: 861M vs. VCYT (321M). ARVN has less debt than VCYT: ARVN (9.9M) vs VCYT (50.6M). VCYT has higher revenues than ARVN: VCYT (479M) vs ARVN (373M).
ARVNVCYTARVN / VCYT
Capitalization570M2.36B24%
EBITDA-112.6M52M-217%
Gain YTD-59.520-24.369244%
P/E RatioN/A88.09-
Revenue373M479M78%
Total Cash861M321M268%
Total Debt9.9M50.6M20%
FUNDAMENTALS RATINGS
ARVN vs VCYT: Fundamental Ratings
ARVN
VCYT
OUTLOOK RATING
1..100
1865
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
73
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6454
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARVN's Valuation (14) in the Biotechnology industry is somewhat better than the same rating for VCYT (73). This means that ARVN’s stock grew somewhat faster than VCYT’s over the last 12 months.

ARVN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VCYT (100). This means that ARVN’s stock grew similarly to VCYT’s over the last 12 months.

ARVN's SMR Rating (100) in the Biotechnology industry is in the same range as VCYT (100). This means that ARVN’s stock grew similarly to VCYT’s over the last 12 months.

VCYT's Price Growth Rating (54) in the Biotechnology industry is in the same range as ARVN (64). This means that VCYT’s stock grew similarly to ARVN’s over the last 12 months.

VCYT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ARVN (100). This means that VCYT’s stock grew similarly to ARVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARVNVCYT
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 17 days ago
72%
Declines
ODDS (%)
Bearish Trend 10 days ago
80%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QIACX52.62N/A
N/A
Federated Hermes MDT All Cap Core IS
TRPWX23.58N/A
N/A
Nuveen Quant Mid Cap Growth R6
TRMCX33.10N/A
N/A
T. Rowe Price Mid-Cap Value
HNVIX36.62N/A
N/A
Heartland Value Plus Institutional
STRNX58.68N/A
N/A
Sterling Capital MdCp Relatv Val C

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
-3.96%
AXON - ARVN
46%
Loosely correlated
+1.59%
VCYT - ARVN
46%
Loosely correlated
+4.68%
ERAS - ARVN
40%
Loosely correlated
-0.63%
ATXS - ARVN
40%
Loosely correlated
+0.31%
SRPT - ARVN
40%
Loosely correlated
+1.49%
More